sb 203580 has been researched along with apicularen b in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (apicularen b) | Trials (apicularen b) | Recent Studies (post-2010) (apicularen b) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 8 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, JW; Hong, J; Ishihara, K; Ohuchi, K; Yamaki, K; Zee, O | 1 |
1 other study(ies) available for sb 203580 and apicularen b
Article | Year |
---|---|
Induction of apoptosis of RAW 264.7 cells by the cytostatic macrolide apicularen A.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Caspases; Cell Line; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Imidazoles; Macrolides; Macrophages; Mice; Molecular Structure; Organic Chemicals; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines | 2003 |